LeMaitre Vascular Q2 FY26 EPS rises 23% to $0.74; net sales increase 10% to $70.4 million

Reuters2026/08/04 20:37

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

LeMaitre Vascular posted Q2 net sales of $70.4 million, up 10% year over year; diluted EPS climbed 23% to $0.74.
Operating income rose 26% to $20.4 million; gross margin widened 2.1 percentage points to 72.1%.
Cash increased $9 million sequentially to $376.2 million; a $0.25-per-share quarterly dividend is payable Sept. 3 to holders of record Aug. 20.
Artegraft sales increased 34%; catheters fell 11% due to recall-driven overstocking in Q2 2025.
Guidance calls for Q3 net sales of $66.3 million-$68.3 million, EPS of $0.66-$0.71; full-year net sales of $274.3 million-$278.3 million, EPS of $2.84-$2.94.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LeMaitre Vascular Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608041605PRIMZONEFULLFEED9803652) on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

LeMaitre Vascular Q2 FY26 EPS rises 23% to $0.74; net sales increase 10% to $70.4 million

You may also like

Crypto prices